These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 25199881)

  • 1. Microarray-based detection and expression analysis of extracellular matrix proteins in drug‑resistant ovarian cancer cell lines.
    Januchowski R; Zawierucha P; Ruciński M; Zabel M
    Oncol Rep; 2014 Nov; 32(5):1981-90. PubMed ID: 25199881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression analysis of drug-resistant MCF-7 cells: implications for relation to extracellular matrix proteins.
    Işeri OD; Kars MD; Arpaci F; Gündüz U
    Cancer Chemother Pharmacol; 2010 Feb; 65(3):447-55. PubMed ID: 19543729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug transporter expression profiling in chemoresistant variants of the A2780 ovarian cancer cell line.
    Januchowski R; Zawierucha P; Ruciński M; Andrzejewska M; Wojtowicz K; Nowicki M; Zabel M
    Biomed Pharmacother; 2014 May; 68(4):447-53. PubMed ID: 24814220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular matrix proteins expression profiling in chemoresistant variants of the A2780 ovarian cancer cell line.
    Januchowski R; Zawierucha P; Ruciński M; Nowicki M; Zabel M
    Biomed Res Int; 2014; 2014():365867. PubMed ID: 24804215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarray-based detection and expression analysis of ABC and SLC transporters in drug-resistant ovarian cancer cell lines.
    Januchowski R; Zawierucha P; Andrzejewska M; Ruciński M; Zabel M
    Biomed Pharmacother; 2013 Apr; 67(3):240-5. PubMed ID: 23462296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
    Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
    Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microarray-based detection and expression analysis of new genes associated with drug resistance in ovarian cancer cell lines.
    Januchowski R; Sterzyńska K; Zawierucha P; Ruciński M; Świerczewska M; Partyka M; Bednarek-Rajewska K; Brązert M; Nowicki M; Zabel M; Klejewski A
    Oncotarget; 2017 Jul; 8(30):49944-49958. PubMed ID: 28611294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiling of a clonal isolate of oxaliplatin-resistant ovarian carcinoma cell line A2780/C10.
    Varma RR; Hector SM; Clark K; Greco WR; Hawthorn L; Pendyala L
    Oncol Rep; 2005 Oct; 14(4):925-32. PubMed ID: 16142353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of gene expression profiles associated with cisplatin resistance in human ovarian cancer cell lines and tissues using cDNA microarray.
    Sakamoto M; Kondo A; Kawasaki K; Goto T; Sakamoto H; Miyake K; Koyamatsu Y; Akiya T; Iwabuchi H; Muroya T; Ochiai K; Tanaka T; Kikuchi Y; Tenjin Y
    Hum Cell; 2001 Dec; 14(4):305-15. PubMed ID: 11925933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular description of evolving paclitaxel resistance in the SKOV-3 human ovarian carcinoma cell line.
    Lamendola DE; Duan Z; Yusuf RZ; Seiden MV
    Cancer Res; 2003 May; 63(9):2200-5. PubMed ID: 12727840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Significance of MicroRNAs Expression in Regulation of Extracellular Matrix and Other Drug Resistant Genes in Drug Resistant Ovarian Cancer Cell Lines.
    Kazmierczak D; Jopek K; Sterzynska K; Ginter-Matuszewska B; Nowicki M; Rucinski M; Januchowski R
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiles with cDNA microarray reveal RhoGDI as a predictive marker for paclitaxel resistance in ovarian cancers.
    Goto T; Takano M; Sakamoto M; Kondo A; Hirata J; Kita T; Tsuda H; Tenjin Y; Kikuchi Y
    Oncol Rep; 2006 May; 15(5):1265-71. PubMed ID: 16596196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma.
    Kumar A; Soprano DR; Parekh HK
    Cancer Res; 2001 Oct; 61(20):7552-5. PubMed ID: 11606393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gene expression profiling of human ovarian epithelial tumors by digo nucleotide microarray].
    Konno R
    Hum Cell; 2001 Dec; 14(4):261-6. PubMed ID: 11925926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of microRNAs in drug-resistant ovarian cancer cells.
    Sorrentino A; Liu CG; Addario A; Peschle C; Scambia G; Ferlini C
    Gynecol Oncol; 2008 Dec; 111(3):478-86. PubMed ID: 18823650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
    Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
    Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microarray analysis revealed dysregulation of multiple genes associated with chemoresistance to As(2)O(3) and increased tumor aggressiveness in a newly established arsenic-resistant ovarian cancer cell line, OVCAR-3/AsR.
    Ong PS; Chan SY; Ho PC
    Eur J Pharm Sci; 2012 Feb; 45(3):367-78. PubMed ID: 22178533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Expression of Several Collagen Genes is Associated with Drug Resistance in Ovarian Cancer Cell Lines.
    Januchowski R; Świerczewska M; Sterzyńska K; Wojtowicz K; Nowicki M; Zabel M
    J Cancer; 2016; 7(10):1295-310. PubMed ID: 27390605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells.
    Okamoto A; Nikaido T; Ochiai K; Takakura S; Saito M; Aoki Y; Ishii N; Yanaihara N; Yamada K; Takikawa O; Kawaguchi R; Isonishi S; Tanaka T; Urashima M
    Clin Cancer Res; 2005 Aug; 11(16):6030-9. PubMed ID: 16115948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy resistance induced by interleukin-6 in ovarian cancer cells and its signal transduction pathways].
    Wang Y; Li LZ; Ye L; Niu XL; Liu X; Zhu YQ; Sun WJ; Liang YJ
    Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):691-8. PubMed ID: 21092551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.